Question 1

What specific symptoms of schizophrenia does this trial address?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glycine Treatment of Prodromal Symptoms clinical trial (NCT00268749). Contact the study team or your healthcare provider for specific answers.

Question 2

How does glycine work in treating these early symptoms?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glycine Treatment of Prodromal Symptoms clinical trial (NCT00268749). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of taking glycine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glycine Treatment of Prodromal Symptoms clinical trial (NCT00268749). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glycine Treatment of Prodromal Symptoms clinical trial (NCT00268749). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glycine Treatment of Prodromal Symptoms clinical trial (NCT00268749). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other treatment options available that I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glycine Treatment of Prodromal Symptoms clinical trial (NCT00268749). Contact the study team or your healthcare provider for specific answers.

What this study is about